Zura Bio Limited
ZURA
$5.73
-$0.41-6.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -85.74M | -75.43M | -68.65M | -65.10M | -67.76M |
| Total Depreciation and Amortization | 61.00K | 56.00K | 49.00K | 39.00K | 28.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.74M | 8.77M | 7.42M | 12.65M | 22.77M |
| Change in Net Operating Assets | 1.40M | -6.07M | -3.63M | -949.00K | 1.39M |
| Cash from Operations | -77.55M | -72.68M | -64.82M | -53.36M | -43.57M |
| Capital Expenditure | -86.00K | -77.00K | -113.00K | -141.00K | -122.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Investing | -86.00K | -77.00K | -113.00K | -141.00K | -122.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 131.90M | 131.90M | 5.40M | 5.59M | 11.12M |
| Repurchase of Common Stock | -7.50M | -41.00K | -41.00K | -352.00K | -352.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.88M | -4.08M | -7.53M | -936.00K | -1.03M |
| Cash from Financing | 128.28M | 127.78M | -2.16M | 4.30M | 9.74M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 50.64M | 55.03M | -67.09M | -49.20M | -33.95M |